Photocure ASA - Invitation to a presentation of the 3rd quarter report 2011
Invitation to a presentation of the 3rd quarter report 2011
Photocure ASA will present its third quarter 2011 report on Wednesday October
26(th), 2011 at Shippingklubben, Haakon VIIs gate 1 (top floor), Oslo, Norway.
The presentation will begin at 11.30 (CET). Representatives from the company
will be Kjetil Hestdal, President & CEO and Christian Fekete, CFO.
The presentation will be publicly available at www.photocure.com. It will be
possible to follow the presentation
on: http://webtv.hegnar.no/webcast.php?id=34825
The presentation is scheduled to conclude at 12:15.
Please register your attendance at Photocure ASA by Tuesday October
25(th), 2011 at 14:00.
Contact person: Grete Faye-Schjøll (e-mail:gfs@photocure.no / phone
+47 22 06 22 10 / fax +47 22 06 22 18).
Best regards,
Christian Fekete, CFO
Photocure ASA
About Photocure ASA
Photocure ASA is a worldwide leader in photodynamic technology. Listed on the
Oslo Stock Exchange (OSE: PHO), Photocure is focused on photodynamic
technologies in dermatology and cancer. The company strives to solve unmet needs
by developing new and innovative solutions based on its patented Photocure
Technology(TM). Photocure markets and sells its own products in selected markets
and has developed strong partnerships with leading pharmaceutical companies on a
regional and global basis. Photocure's bladder cancer diagnostic product, Hexvix
is approved in Europe and the US. In addition, the company markets Allumera®, a
photodynamic cosmetic in the US. Setting new standards for diagnosis and
treatment of several different conditions, Photocure Technology(TM) is
continuously being tested for new products and applications in cancer and
dermatology.
Allumera®, Photocure® and Hexvix® are registered trademarks of Photocure ASA.
For more information about Photocure, visitwww.photocure.com.
This information is subject of the disclosure requirements acc. to §5-12 vphl
(Norwegian Securities Trading Act)
[HUG#1557324]